Sort   by:  
 Page size 
UnknownEstablishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.
Not available
S-EPMC10792481 | biostudies-literature
UnknownAbagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.
Not available
S-EPMC5795662 | biostudies-literature
UnknownThe role of apoptotic cell death in the radiosensitising effect of gemcitabine.
Not available
S-EPMC2736812 | biostudies-literature
UnknownRandomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study).
Not available
S-EPMC5086582 | biostudies-literature
UnknownBiomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer.
Not available
S-EPMC5834024 | biostudies-literature
Unknown20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
Not available
S-EPMC5734609 | biostudies-literature
UnknownPhase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.
Not available
S-EPMC2724854 | biostudies-literature
UnknownEffect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
Not available
S-EPMC5015598 | biostudies-literature
UnknownRelevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Not available
S-EPMC3163848 | biostudies-literature
UnknownEffect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
Not available
S-EPMC3254252 | biostudies-literature
Sort   by:  
 Page size